Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Cell-based and Recombinant vs Egg-based Influenza Vaccines in HCP
NCT03722589Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Sep 2018
- Primary completion
- Jul 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Fluzone Trivalent, influenza vaccine in influenza, sponsored by Centers for Disease Control and Prevention. Started Sep 2018; status: completed.
02
Drugs
Fluzone Trivalentinfluenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03722589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03722589.